Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 02:11 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Antiretroviral Therapy for Acute HIV Infection
NCT03877536 · Henry M. Jackson Foundation for the Advancement of Military Medicine · NA · withdrawn · last registry update 2019-04-26 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “Feeder cohort study closed.” | – | Registry record, Henry M. Jackson Foundation for the Advancement of Military Medicine |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against CYP3A4 within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2020-03-18Also stopped (withdrawn): Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic, Elvitegravir, Cobicistat, TAF, FTC + Efavirenz, TDF, and 3TC (NCT03405194)
- 2020-02-05Phase 3 first posted: Shanghai Public Health Clinical Center, Darunavir and Cobicistat (NCT04252274)
- 2020-01-07Results posted on the registry: Janssen Scientific Affairs, LLC, DRV 800 mg + COBI 150 mg + FTC 200 mg + TAF 10 mg FDC (NCT03227861)
- 2019-12-05Results posted on the registry: Gilead Sciences, B/F/TAF (NCT03405935)
- 2019-11-26Results posted on the registry: Medicines for Malaria Venture, Single oral dose of 800 mg OZ439 + Single oral dose of 400 mg OZ439 (NCT04069221)
- 2019-11-04Results posted on the registry: Gilead Sciences, E/C/F/TAF (NCT02616029)
- 2019-10-31Results posted on the registry: University of California, San Diego, Stribild + Genvoya (NCT02251236)
- 2019-09-17Results posted on the registry: Emory University, Truvada + Genvoya (NCT02985996)
- 2019-05-29Results posted on the registry: GlaxoSmithKline, GSK2838232 + Cobicistat (NCT03045861)
- 2019-04-03Results posted on the registry: Merck Sharp & Dohme LLC, Doravirine, Tenofovir, Lamivudine + Baseline regimen of ritonavir- or cobicistat-boosted protease inhibitor (NCT02397096)
- 2019-02-19Results posted on the registry: Gilead Sciences, E/C/F/TAF + TDF (NCT02616783)
- 2018-11-09Results posted on the registry: Janssen R&D Ireland, D/C/F/TAF + Boosted Protease Inhibitor (bPI) (NCT02269917)
- 2018-11-02Results posted on the registry: Gilead Sciences, E/C/F/TAF + E/C/F/TDF (NCT02652624)
- 2018-10-16Results posted on the registry: Gilead Sciences, E/C/F/TAF + B/F/TAF (NCT02600819)
- 2018-10-09Results posted on the registry: Gilead Sciences, E/C/F/TAF + F/R/TAF (NCT02707601)
- 2018-10-04Phase 3 first posted: NEAT ID Foundation, Biktarvy + Symtuza (NCT03696160)
- 2018-09-14Results posted on the registry: Janssen Sciences Ireland UC, Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide FDC + DRV/COBI FDC (NCT02431247)
- 2018-08-15Phase 3 first posted: Gilead Sciences, B/F/TAF + NRTIs (NCT03631732)
- 2018-07-13Results posted on the registry: Gilead Sciences, E/C/F/TAF + ABC/3TC (NCT02605954)
- 2018-06-12Results posted on the registry: Janssen Pharmaceutical K.K., Darunavir/Cobicistat (NCT03123848)
- 2018-06-11Results posted on the registry: Gilead Sciences, F/TAF + ABC/3TC (NCT02469246)
- 2018-06-06Results posted on the registry: Gilead Sciences, RTV + ATV (NCT02603107)
- 2018-05-08Results posted on the registry: University of Washington, Stribild (Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF) 1 tablet daily X 48 weeks (NCT02180438)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision